Compare · ALGN vs COCH
ALGN vs COCH
Side-by-side comparison of Align Technology Inc. (ALGN) and Envoy Medical Inc. (COCH): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both ALGN and COCH operate in Industrial Specialties (Health Care), so they compete in similar markets.
- ALGN is the larger of the two at $10.26B, about 208.6x COCH ($49.2M).
- Over the past year, ALGN is up 12.8% and COCH is down 22.4% - ALGN leads by 35.2 points.
- Both names hit the wire about 4 times in the past 4 weeks.
- ALGN has more recent analyst coverage (25 ratings vs 3 for COCH).
- Company
- Align Technology Inc.
- Envoy Medical Inc.
- Price
- -
- -
- Market cap
- $10.26B
- $49.2M
- 1M return
- -2.26%
- -4.15%
- 1Y return
- +12.77%
- -22.45%
- Industry
- Industrial Specialties
- Industrial Specialties
- Exchange
- NASDAQ
- NASDAQ
- IPO
- 2001
- 2021
- News (4w)
- 4
- 4
- Recent ratings
- 25
- 3
Align Technology Inc.
Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.
Latest ALGN
- Align Tech downgraded by Robert W. Baird with a new price target
- Align Tech downgraded by Evercore ISI with a new price target
- Align Technology to Announce Third Quarter 2026 Results on October 28, 2026
- Align Technology Launches “SHIFT Happens” U.S. Campaign to Educate Adults About Lifelong Tooth Movement
- Align Technology to Speak at Upcoming Financial Conference
- SEC Form 4 filed by Director Blackford Quentin S.
- SEC Form 3 filed by new insider Blackford Quentin S.
- Align Technology Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- Quentin Blackford to Join Align Technology Board of Directors
- Align Technology Prevails in China Patent Infringement Action Against Angelalign
Latest COCH
- Envoy Medical Submits Second Module of Modular Premarket Approval Application to FDA for Breakthrough Designated Acclaim(R) Cochlear Implant
- SEC Form 8-K filed by Envoy Medical Inc.
- Lake Street initiated coverage on Envoy Medical with a new price target
- Envoy Medical Announces New Patents, Further Expanding Global Patent Portfolio
- SEC Form DEFA14A filed by Envoy Medical Inc.
- Envoy Medical to Present at the H.C. Wainwright 28th Annual Global Investment Conference on September 14th-16th
- SEC Form DEF 14A filed by Envoy Medical Inc.
- Envoy Medical Inc. filed SEC Form 8-K: Leadership Update, Financial Statements and Exhibits
- SEC Form 4 filed by CAO & VP of Finance Potashnick Robert
- SEC Form PRE 14A filed by Envoy Medical Inc.